Welcome to the TAPUR study! The TAPUR study is a clinical trial for patients with advanced cancer who have not responded, or have stopped responding to standard treatment and who possibly have a genomic variation that can be targeted with anti-cancer drugs – so-called “actionable genomic variants.”
To find out if you may be eligible for the TAPUR study, review the eligibility criteria section below.
The TAPUR study is enrolling patients at participating clinical sites. Review the statements below to find out if you may be eligible for the TAPUR study. If you agree with all of the below statements, you may qualify for the TAPUR study. Discuss with your doctor, or for more information, contact the TAPUR study team using the contact us form below.
The ASCO TAPUR team recognizes that cancer research advocates are important stakeholders and partners in clinical trials and can contribute to the planning and conduct of the TAPUR study, as well as assist in increasing public and patient awareness. We welcome advocates to complete our brief online survey and sign up to receive communications and updates about TAPUR and for those interested, information on how to get involved.
NETWORK OF CENTERS
TAPUR is now enrolling patients at cancer centers and networks across the country. Additional sites will be brought on throughout 2016 and 2017.
Patient information from the American Society of Clinical Oncology (ASCO). Includes information on cancer types, treatments, survivorship, advocacy, and additional resources.